Effects of cilostazol on late lumen loss after Palmaz-Schatz stent implantation
- 1 August 1998
- journal article
- clinical trial
- Published by Wiley in Catheterization and Cardiovascular Diagnosis
- Vol. 44 (4) , 387-391
- https://doi.org/10.1002/(sici)1097-0304(199808)44:4<387::aid-ccd4>3.0.co;2-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Pharmacologic Treatment of Intimal Hyperplasia After Metallic Stent Placement in the Peripheral ArteriesInvestigative Radiology, 1995
- Luminal loss and site of restenosis after Palmaz-Schatz coronary stent implantationThe American Journal of Cardiology, 1995
- Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six monthsThe Lancet, 1994
- Serial angiographic follow-up after palmaz-schatz stent implantation: Comparison with conventional balloon angioplastyJournal of the American College of Cardiology, 1993
- Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomyJournal of the American College of Cardiology, 1993
- Effect of Cilostazol, a Cyclic AMP Phosphodiesterase Inhibitor, on the Proliferation of Rat Aortic Smooth Muscle Cells in CultureJournal of Cardiovascular Pharmacology, 1992
- Wiktor stent implantation in patients with restenosis following balloon angioplasty of a native coronary arteryThe American Journal of Cardiology, 1992
- Effects of low-dose aspirin on restenosis after coronary angioplastyThe American Journal of Cardiology, 1991
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988
- Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.Circulation, 1985